Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report
Emergency and Critical Care Medicine · 2022
DOI: 10.1097/ec9.0000000000000034 ↗Kurz gefasst
Fallbericht in der Zeitschrift Emergency and Critical Care Medicine, 2022. Verfasst von Lina Pan und 9 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A middle-aged man was diagnosed with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U), with severe and extensive corticosteroid-resistant Sweet’s syndrome (SS) as the first manifestation, with evidence of clinical manifestations, pathological description, and laboratory evaluation. The skin lesions continued to spread despite treatment with systemic corticosteroids but were successfully treated with intravenous immunoglobulin (IVIG).
Zitieren
APA
Pan, L., Zhang, J., Li, P., Zhao, C., Zang, S., Ji, M., Lu, F., Ye, J., Zhang, C., & Ji, C. (2022). Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report. Emergency and Critical Care Medicine. https://doi.org/10.1097/ec9.0000000000000034
Vancouver
Pan L, Zhang J, Li P, Zhao C, Zang S, Ji M, et al. Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report. Emergency and Critical Care Medicine. 2022. doi:10.1097/ec9.0000000000000034
BibTeX
@article{Pan2022,
author = {Pan, Lina and Zhang, Jingru and Li, Peng and Zhao, Chuanli and Zang, Shaolei and Ji, Min and Lu, Fei and Ye, Jingjing and Zhang, Chunqing and Ji, Chunyan},
title = {Corticosteroid-resistant Sweet’s syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report},
journal = {Emergency and Critical Care Medicine},
year = {2022},
doi = {10.1097/ec9.0000000000000034}
}
EUVIMED